Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Camila Pupe is active.

Publication


Featured researches published by Camila Pupe.


Neurology International | 2015

Amyotrophic lateral sclerosis: new perpectives and update

Marco Orsini; Acary Souza Bulle de Oliveira; Osvaldo J. M. Nascimento; Carlos Henrique Melo Reis; Marco Antonio Araujo Leite; Jano Alves de Souza; Camila Pupe; Olivia Gameiro de Souza; Victor Hugo Bastos; Marcos R.G. de Freitas; Silmar Teixeira; Carlos Bruno; Eduardo Davidovich; Benny Smidt

Amyotrophic lateral sclerosis (ALS), Charcot’s disease or Lou Gehrig’s disease, is a term used to cover the spetrum of syndromes caracterized by progressive degeneration of motor neurons, a paralytic disorder caused by motor neuron degeneration. Currently, there are approximately 25,000 patients with ALS in the USA, with an average age of onset of 55 years. The incidence and prevalence of ALS are 1-2 and 4-6 per 100,000 each year, respectively, with a lifetime ALS risk of 1/600 to 1/1000. It causes progressive and cumulative physical disabilities, and leads to eventual death due to respiratory muscle failure. ALS is diverse in its presentation, course, and progression. We do not yet fully understand the causes of the disease, nor the mechanisms for its progression; thus, we lack effective means for treating this disease. In this chapter, we will discuss the diagnosis, treatment, and how to cope with impaired function and end of life based on of our experience, guidelines, and clinical trials. Nowadays ALS seems to be a more complex disease than it did two decades – or even one decade – ago, but new insights have been plentiful. Clinical trials should be seen more as experiments on pathogenic mechanisms. A medication or combination of medications that targets more than one pathogenic pathway may slow disease progression in an additive or synergistic fashion.


Arquivos De Neuro-psiquiatria | 2012

Leprosy late-onset neuropathy: an uncommon presentation of leprosy

Osvaldo J. M. Nascimento; Marcos R.G. de Freitas; Tania M Escada; Wilson Marques Junior; Fernando Cardoso; Camila Pupe; Sandra Maria Barbosa Durães

Clinical and pathological findings in leprosy are determined by the natural host immune response to Mycobacterium leprae. We previously described cases of painful neuropathy (PN) with no concurrent cause apart from a past history of leprosy successfully treated. Four leprosy previously treated patients who developed a PN years after multidrug therapy (MDT) are reported. The mean patient age was 52.75 years (47-64). The mean time interval of the recent neuropathy from the previous MDT was 19 years (12-26). A painful multiplex neuritis or polyneuropathy were observed respectively in two cases. Electrophysiological studies disclosed a sensory axonal neuropathy in two cases. Microvasculitis with no bacilli was seen in nerve biopsy. Neuropathic symptoms were improved with prednisone. We consider these cases as being a leprosy late-onset neuropathy (LLON) form of presentation. A delayed immune reaction could explain the late appearance of LLON.


Neurology International | 2016

Neuropathic pain treatment: still a challenge

Osvaldo J. M. Nascimento; Bruno Pessoa; Marco Orsini; Pedro Ribeiro; Eduardo Davidovich; Camila Pupe; Pedro Ferreira Moreira Filho; Ricardo Dornas; Lucas Masiero; Juliana Bittencourt; Victor Hugo do Vale Bastos

Neuropathic pain (NP) is the result of a series of conditions caused by diseases or lesions to the somatosensory system. Due to the better understanding of NP pathophysiology previously unexplored therapies have been used with encouraging results. In this group, acetyl-L-carnitine, alpha-lipoic-acid, cannabinoids, clonidine, EMA401, botulinum toxin type A and new voltage-gated sodium channel blockers, can be included. Besides, changing paradigms may occur with the advent of optogenetics and a better understanding of epigenetic regulation. We reviewed the published literature on the pharmacological treatment of NP. Despite the interesting results, randomized controlled trials are demanded the majority of the therapies previously mentioned. In spite of several studies for the relief of NP, pain control continues being a challenge.


Arquivos De Neuro-psiquiatria | 2015

Corneal confocal microscopy in a healthy Brazilian sample

Gabriela Dieckmann; Camila Pupe; Osvaldo J. M. Nascimento

OBJECTIVE This study aims to evaluate the characteristics of the corneal sub-basal plexus by performing in vivo confocal microscopy of healthy Brazilians to provide reference values for the Brazilian population. METHOD This study is an observational, cross-sectional, descriptive study comparing corneas from 55 healthy Brazilian individuals across the age span of 20-70 years. RESULTS The average number of fibers was 5.35 ± 1.36, fiber density was 33.4 ± 8.5 fibers per field, and the mean number of Langerhans cells was 5.13 ± 8.10. A correlation between the average number of fibers and age showed an inverse relationship between the number and density of fibers and age for women (p < 0.05). In the multivariate analysis, each annual increase of age showed an average increase of 1.017 (95%CI: 1.008 to 1.026) in the number of Langerhans cells, adjusting for sex and thickness. CONCLUSION Compared to other samples, this Brazilian population showed a higher average number of fibers, though further studies with a larger sample should be performed.


Arquivos De Neuro-psiquiatria | 2012

Mitochondrial neurogastrointestinal encephalomyopathy mimicking chronic inflammatory demyelinating polyradiculoneuropathy.

Camila Pupe; Osvaldo J. M. Nascimento; Giseli Quintanilha; Marcos R.G. de Freitas; Eduardo Uchoa; André Palma da Cunha Matta; João Gabriel Dib; Tânia Maria Escada

Departamento de Neurologia e Nucleo de Pesquisa Clinica em Neurologia/Neurociencias da Universidade Federal Fluminense (NeuroUPC-UFF), Rio de Janeiro, Brazil.Correspondence: Osvaldo J. M. Nascimento; Rua Siqueira Campos 53/1204; 22031-070 Rio de Janeiro RJ - Brasil; Email: [email protected] Conflict of interest: There is no conflict of interest to declare.Received 08 September 2011; Received in final form 14 October 2011; Accepted 21 October 2011


Neurology International | 2016

Revisiting the Term Neuroprotection in Chronic and Degenerative Diseases.

Marco Orsini; Osvaldo J. M. Nascimento; André Palma da Cunha Matta; Carlos Henrique Melo Reis; Olivia Gameiro de Souza; Victor Hugo Bastos; Rayele Moreira; Pedro Ribeiro; Stenio Fiorelli; Pietro Novellino; Bruno Pessoa; Mariana Cunha; Camila Pupe; Pedro S. Morales; Pedro Ferreira Moreira Filho; Eduardo Trajano; Acary Souza Bulle de Oliveira

Thanks to the development of several new researches, the lifetime presented a significant increase, even so, we still have many obstacles to overcome – among them, manage and get responses regarding neurodegenerative diseases. Where we are in the understanding of neuroprotection? Do we really have protective therapies for diseases considered degeneratives such as amyotrophic lateral sclerosis and its variants, Parkinson’s disease, Alzheimer’s disease and many others? Neuroprotection is defined by many researches as interactions and interventions that can slow down or even inhibit the progression of neuronal degeneration process. We make some considerations on this neuroprotective effect.


Neurology International | 2015

Palm to Finger Ulnar Sensory Nerve Conduction

Eduardo Davidowich; Osvaldo J. M. Nascimento; Marco Orsini; Camila Pupe; Bruno Pessoa; Caroline Bittar; Karina Pires; Carlos Bruno; Bruno Coutinho; Olivia Gameiro de Souza; Pedro Ribeiro; Bruna Velasques; Juliana Bittencourt; Silmar Teixeira; Victor Hugo Bastos

Ulnar neuropathy at the wrist (UNW) is rare, and always challenging to localize. To increase the sensitivity and specificity of the diagnosis of UNW many authors advocate the stimulation of the ulnar nerve (UN) in the segment of the wrist and palm. The focus of this paper is to present a modified and simplified technique of sensory nerve conduction (SNC) of the UN in the wrist and palm segments and demonstrate the validity of this technique in the study of five cases of type III UNW. The SNC of UN was performed antidromically with fifth finger ring recording electrodes. The UN was stimulated 14 cm proximal to the active electrode (the standard way) and 7 cm proximal to the active electrode. The normal data from amplitude and conduction velocity (CV) ratios between the palm to finger and wrist to finger segments were obtained. Normal amplitude ratio was 1.4 to 0.76. Normal CV ratio was 0.8 to 1.23.We found evidences of abnormal SNAP amplitude ratio or substantial slowing of UN sensory fibers across the wrist in 5 of the 5 patients with electrophysiological-definite type III UNW.


Arquivos De Neuro-psiquiatria | 2018

Definition and diagnosis of small fiber neuropathy: consensus from the Peripheral Neuropathy Scientific Department of the Brazilian Academy of Neurology

Francisco de Assis Aquino Gondim; Amilton Antunes Barreira; Rinaldo Claudino; Márcia Waddington Cruz; Francisco Marcos Bezerra da Cunha; Marcos R.G. de Freitas; Marcondes C. França; Marcus Vinicius Magno Goncalves; Wilson Marques; Osvaldo J. M. Nascimento; Acary Souza Bulle Oliveira; Raquel Campos Pereira; Camila Pupe; Francisco Tellechea Rotta; Pedro Schestatsky

The aim of this study was to describe the results of a Brazilian Consensus on Small Fiber Neuropathy (SFN). Fifteen neurologists (members of the Brazilian Academy of Neurology) reviewed a preliminary draft. Eleven panelists got together in the city of Fortaleza to discuss and finish the text for the manuscript submission. Small fiber neuropathy can be defined as a subtype of neuropathy characterized by selective involvement of unmyelinated or thinly myelinated sensory fibers. Its clinical picture includes both negative and positive manifestations: sensory (pain/dysesthesias/pruritus) or combined sensory and autonomic complaints, associated with an almost entirely normal neurological examination. Standard electromyography is normal. A growing list of medical conditions is associated with SFN. The classification of SFN may also serve as a useful terminology to uncover minor discrepancies in the normal values from different neurophysiology laboratories. Several techniques may disclose sensory and/or autonomic impairment. Further studies are necessary to refine these techniques and develop specific therapies.


Arquivos De Neuro-psiquiatria | 2018

Pain in Charcot-Marie-Tooth disease: an update

Helen Azevedo; Camila Pupe; Rouse Pereira; Osvaldo J. M. Nascimento

Charcot-Marie-Tooth (CMT) disease, the most common inherited peripheral neuropathy, has pain as one of its clinical features, yet it remains underdiagnosed and undertreated. This literature review assessed data related to pain from CMT to determine its prevalence, type and importance as a symptom, which, unlike other symptoms, is likely to be treated. The research encompassed 2007 to 2017 and included five articles that addressed pain from CMT. All of the papers concurred that pain is frequently present in CMT patients, yet its classification remains undefined as there has been no consensus in the literature about the mechanisms that cause it.


Arquivos De Neuro-psiquiatria | 2016

Currents issues in cardiorespiratory care of patients with post-polio syndrome

Marco Orsini; Agnaldo José Lopes; Fernando Silva Guimarães; Marcos R.G. de Freitas; Osvaldo J. M. Nascimento; Mauricio de Sant' Anna Junior; Pedro Ferreira Moreira Filho; Stenio Fiorelli; A.C.A.F. Ferreira; Camila Pupe; Victor Hugo Bastos; Bruno Pessoa; Carlos Bruno Nogueira; Beny Schmidt; Olivia Gameiro e Souza; Eduardo Davidovich; Acary Souza Bulle Oliveira; Pedro Ribeiro

METHOD A search for papers was made in the databases Bireme, Scielo and Pubmed with the following keywords: post polio syndrome, cardiorespiratory and rehabilitation in English, French and Spanish languages. Although we targeted only seek current studies on the topic in question, only the relevant (double-blind, randomized-controlled and consensus articles) were considered. RESULTS AND DISCUSSION Certain features of PPS such as generalized fatigue, generalized and specific muscle weakness, joint and/or muscle pain may result in physical inactivity deconditioning obesity and dyslipidemia. Respiratory difficulties are common and may result in hypoxemia. CONCLUSION Only when evaluated and treated promptly, somE patients can obtain the full benefits of the use of respiratory muscles aids as far as quality of life is concerned.

Collaboration


Dive into the Camila Pupe's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Eduardo Davidovich

Federal Fluminense University

View shared research outputs
Top Co-Authors

Avatar

Bruno Coutinho

Federal Fluminense University

View shared research outputs
Top Co-Authors

Avatar

Marco Orsini

Federal Fluminense University

View shared research outputs
Top Co-Authors

Avatar

Ricardo Dornas

Federal Fluminense University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Bruno Pessoa

Federal Fluminense University

View shared research outputs
Top Co-Authors

Avatar

Carlos Bruno Nogueira

Federal Fluminense University

View shared research outputs
Top Co-Authors

Avatar

Caroline Amaral

Federal Fluminense University

View shared research outputs
Top Co-Authors

Avatar

Karina Pires

Federal Fluminense University

View shared research outputs
Researchain Logo
Decentralizing Knowledge